Articles

A cross-sectional study investigates how this supply chain link helps increase Medicare Part D spending on self-administered specialty drugs.

Identifying Trends Surrounding the Use of In-House Pharmacies for High-Cost Drugs

SKYTyphoid, a single-dose typhoid conjugate vaccine jointly developed by SK bioscience and the International Vaccine Institute, showed a positive immunogenicity and safety profile across age groups.

World Health Organization Grants Prequalification to Typhoid Conjugate Vaccine 

The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.

Fortrea Grows Its Non-Commercial Specialty Pharma Offering

Trial data show Dupixent is the first and only novel biologic drug to significantly improve lung function and reduce severe acute exacerbations in adults with uncontrolled chronic obstructive pulmonary disease.

Dupixent sBLA Gets FDA Priority Review for Treatment of COPD With Type 2 Inflammation

The latest news for pharma industry insiders. 

Why M&A is back; AI regulations lacking; quantum sensing investment, and more: Pharma Pulse for February 23, 2024

The annual report published by IQVIA examines movement surrounding drug launches and new clinical trials, during the post-pandemic era.

Investigating Trends in the Pharmaceutical Research & Development Space

A cohort study investigates how a change in clinical guidelines, an expanded label, and reduction in drug prices can impact the use of PCSK9 inhibitors as a treatment for atherosclerotic cardiovascular disease.

Analyzing PCSK9 Inhibitor Use in Adults With Cardiovascular Disease

Immune-Onc Therapeutics’ IO-202 is currently being analyzed as a monotherapy and in combination for patients with relapsed/refractory acute myeloid leukemia with monocytic differentiation or chronic myelomonocytic leukemia.

First-in-Class Novel Therapy for Chronic Myelomonocytic Leukemia Granted FDA Orphan Drug Designation 

Ocifisertib (CFI-400945) is a first-in-class, novel PLK4 inhibitor that has been found to regulate centriole duplication in patients with acute myeloid leukemia. 

FDA Grants Orphan Drug Designation to Novel Treatment for Acute Myeloid Leukemia 

OneScan 7.1 is expected to boost compliance, while also improving pharma supply chain efficiencies.  

News